Correction to: Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-Analysis
The authors would like to replace 2 small sections of the published manuscript that refer to a qualitative review of safety data for included studies (together with an associated safety table), to provide some further clarifications on these safety data and to include some quantitative updates for r...
Main Authors: | Kyle Fahrbach, Jialu Tarpey, Evelien Bergrath Washington, Rachel Hughes, Howard Thom, Maureen P. Neary, Amy Cha, Robert Gerber, Joseph C. Cappelleri |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-10-01
|
Series: | Dermatology and Therapy |
Online Access: | https://doi.org/10.1007/s13555-020-00452-1 |
Similar Items
-
Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-Analysis
by: Kyle Fahrbach, et al.
Published: (2020-05-01) -
Efficacy and Safety of Crisaborole Ointment 2% in Chinese Patients Aged ≥ 2 Years with Mild to Moderate Atopic Dermatitis
by: Lin Ma, et al.
Published: (2024-05-01) -
Direct and Indirect Effects of Crisaborole Ointment on Quality of Life in Patients with Atopic Dermatitis: A Mediation Analysis
by: Eric L. Simpson, et al.
Published: (2019-05-01) -
Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis
by: Joseph Fowler, et al.
Published: (2023-02-01) -
Maintenance of Investigator’s Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis
by: Lawrence F. Eichenfield, et al.
Published: (2024-03-01)